Summit Wealth Group (Colorado)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$797K Buy
3,165
+286
+10% +$61.5K 0.07% 154
2026
Q1
$626K Buy
2,879
+1,483
+106% +$329K 0.07% 153
2025
Q4
$319K Buy
+1,396
New +$318K 0.04% 204
2025
Q3
Sell
-1,211
Closed -$225K 268
2025
Q2
$225K Buy
+1,211
New +$225K 0.06% 221

Other funds holding ABBV

Summit Wealth Group (Colorado)'s ABBV Position: Q2 2026 in Review

Summit Wealth Group (Colorado) increased its AbbVie (ABBV) stake by 9.9% in Q2 2026, buying an estimated $61.5K and bringing the position to 3,165 shares worth $797K. The position accounts for 0.07% of the portfolio, ranked #154.

Summit Wealth Group (Colorado) first reported a position in ABBV in Q2 2025 and has held it in 4 quarters since. 1,977 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Summit Wealth Group (Colorado) held 3,165 shares of AbbVie worth $797K as of Q2 2026.
  • Summit Wealth Group (Colorado) bought 286 AbbVie shares in Q2 2026, an estimated $61.5K.
  • AbbVie made up 0.07% of Summit Wealth Group (Colorado)'s portfolio in Q2 2026, its #154 holding.
  • Summit Wealth Group (Colorado) first reported a position in AbbVie in Q2 2025 and has held it in 4 quarters since.
  • 1,977 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Summit Wealth Group (Colorado)'s 13F filing for Q2 2026, filed 28 Jul 2026.